These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2018046

  • 1. Antiretroviral therapy and immunomodulators in patients with AIDS.
    Groopman JE.
    Am J Med; 1991 Apr 10; 90(4A):18S-21S. PubMed ID: 2018046
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma.
    Fischl MA.
    Am J Med; 1991 Apr 10; 90(4A):2S-7S. PubMed ID: 2018047
    [Abstract] [Full Text] [Related]

  • 3. Treatment of AIDS with combinations of antiretroviral agents: a summary.
    Groopman JE.
    Am J Med; 1991 Apr 10; 90(4A):27S-30S. PubMed ID: 2018049
    [No Abstract] [Full Text] [Related]

  • 4. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.
    Ann Intern Med; 1990 Jun 01; 112(11):812-21. PubMed ID: 1971504
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S.
    Blood; 1990 Aug 01; 76(3):463-72. PubMed ID: 2198957
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE.
    J Clin Oncol; 1991 May 01; 9(5):802-8. PubMed ID: 2016623
    [Abstract] [Full Text] [Related]

  • 7. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE.
    Am J Clin Oncol; 1991 May 01; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [Abstract] [Full Text] [Related]

  • 8. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE, Paredes J, Bundow D, Polsky B, Gold JW, Flomenberg N.
    J Clin Oncol; 1992 Aug 01; 10(8):1344-51. PubMed ID: 1634925
    [Abstract] [Full Text] [Related]

  • 9. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL, Zell SC.
    Am Fam Physician; 1990 May 01; 41(5):1521-8. PubMed ID: 1692180
    [Abstract] [Full Text] [Related]

  • 10. Treatment of AIDS with combinations of antiretroviral agents.
    Merigan TC.
    Am J Med; 1991 Apr 10; 90(4A):8S-17S. PubMed ID: 1850192
    [Abstract] [Full Text] [Related]

  • 11. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus.
    Mitsuyasu RT.
    Rev Infect Dis; 1991 Apr 10; 13(5):979-84. PubMed ID: 1720567
    [Abstract] [Full Text] [Related]

  • 12. Use of hematopoietic hormones for bone marrow defects in AIDS.
    Aboulafia DM.
    Oncology (Williston Park); 1997 Dec 10; 11(12):1827-34, 1839, 1843-4; discussion 1. PubMed ID: 9436189
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
    Hewitt RG, Morse GD.
    Pharmacotherapy; 1992 Dec 10; 12(6):455-61. PubMed ID: 1492010
    [Abstract] [Full Text] [Related]

  • 14. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.
    Miles SA.
    Cancer Invest; 1991 Dec 10; 9(2):229-38. PubMed ID: 1713806
    [Abstract] [Full Text] [Related]

  • 15. [Current developments in the treatment of AIDS].
    Mulder JW.
    Ned Tijdschr Geneeskd; 1989 Aug 19; 133(33):1664-6. PubMed ID: 2477718
    [No Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease.
    Groopman JE.
    Semin Hematol; 1990 Jul 19; 27(3 Suppl 3):8-14. PubMed ID: 2198662
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA.
    AIDS Res Hum Retroviruses; 1992 Jun 19; 8(6):1073-80. PubMed ID: 1380256
    [Abstract] [Full Text] [Related]

  • 18. Methodological issues in AIDS clinical trials. Application of the combination index method in the design of a clinical antiretroviral trial: ACTG 068.
    Mildvan D, Ruprecht R, Krown S, Pettinelli C.
    J Acquir Immune Defic Syndr (1988); 1990 Jun 19; 3 Suppl 2():S111-3 discussion S114-9. PubMed ID: 2231291
    [No Abstract] [Full Text] [Related]

  • 19. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, Metcalf JA, Bigley JW, Sawyer LA, Zoon KC.
    Ann Intern Med; 1989 Aug 15; 111(4):280-7. PubMed ID: 2757312
    [Abstract] [Full Text] [Related]

  • 20. Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study.
    Orholm M, Pedersen C, Mathiesen L, Dowd P, Nielsen JO.
    AIDS; 1989 Feb 15; 3(2):97-100. PubMed ID: 2496726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.